| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |